Teliatry Revenue
Medical Equipment Manufacturing • 
Richardson, Texas, United States • 1-10 Employees
Teliatry revenue & valuation
| Annual revenue | $769,995 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $2,500,000 |
| Total funding | No funding |
Key Contact at Teliatry
Dane Grasse
Chief Technology Officer
Company overview
| Headquarters | 1301 N Plano Rd, Richardson, Texas 75081, US |
| Phone number | +19727921640 |
| Website | |
| NAICS | 3391 |
| Keywords | Manufacturing Class Iii Neuromodulation Implants |
| Founded | 2018 |
| Employees | 1-10 |
| Socials |
Teliatry Email Formats
Teliatry uses 3 email formats. The most common is {first initial} (e.g., j@teliatry.com), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@teliatry.com | 66.7% |
{first initial}{last name} | jdoe@teliatry.com | 16.7% |
{first name} | john@teliatry.com | 16.7% |
About Teliatry
Teliatry is a fast-growing startup aimed at disrupting the medical device industry. We are an ISO 13485:2016 and ISO 9001: 2015 certified medical device manufacturer that designs, develops and manufactures next generation minimally invasive, implantable medical device systems for the neuromodulation, deep brain stimulation, drug delivery, sensing, and multiparameter medical systems global market. Teliatry was founded by members of two pioneers in biomedical device R&D: the Texas Biomedical Device Center (TXBDC) and Zyvex Labs. The company that has emerged from the combined talent and technology of these organizations is revolutionizing biomedical device manufacturing with highly miniaturized and sophisticated class III implants built with 21st century, scalable manufacturing techniques. We have developed a platform technology which we provide as a contract biomedical device manufacturer for biomedical device companies that need minimally invasive, injectable, or highly miniaturized implant systems. Our initial device is a wireless neurostimulator system developed for vagus nerve stimulation. It is implantable with minimally invasive surgery, has an embedded programmable CPU, has undergone extensive biocompatibility and animal studies and is 30X smaller than products in the market today. The system currently has FDA approval for three different early feasibility studies. We have a well-established supply chain for our manufacturing approach that is wafer scale, automated and highly scalable to large volumes, dramatically lowering the cost, while improving the capabilities and reliability over existing manufacturing approaches. The cost per implant system will permit animal studies with the same device that can be taken into human clinical trials saving time and money. This adaptable platform technology is being developed by our experienced and talented design team for an ever-expanding range of uses. Contact us to see what we can do for your therapeutics.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Teliatry has 6 employees across 5 departments.
Departments
Number of employees
Funding Data
Teliatry has never raised funding before.
Teliatry Tech Stack
Discover the technologies and tools that power Teliatry's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Reverse proxies
UI frameworks
Font scripts
Spain
Germany
United Kingdom
South AfricaFrequently asked questions
4.8
40,000 users
